The substrate envelope strategy: Structural basis for resistance mitigation in antiviral drug design
This review highlights the “substrate envelope hypothesis”, a structure-based drug design (SBDD) paradigm that constrains the spatial boundaries and binding footprint of inhibitors within the conserved active site volume defined by natural viral substrates, and extends this strategy from traditional protease targets to...